British volunteer receives Ebola vaccine in second human trial
The Washington Post
By Abby Phillip
A 48-year old British woman became the first volunteer to receive a dose of an experimental Ebola vaccine as a new trial began Wednesday at the University of Oxford.
Ruth Atkins, a former National Health Service nurse, received an injection in her upper arm on Wednesday morning, becoming the first of 60 participants in the trial.
In a statement, Atkins said that she felt "absolutely fine" after receiving what is currently known as the NIAID/GSK vaccine, after the National Institute of Allergy and Infectious Diseases and the pharmaceutical company GlaxoSmithKline.
Click here to read the full story.